Vimarsana
Biggest News Aggregation in the World

Adi Frish News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adi Frish. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adi Frish Today - Breaking & Trending Today

RedHill Biopharma : Announces First Patient Enrolled in U.S. Government- Supported COVID-19 Study - Form 6-K - Vimarsana News

RedHill Biopharma : Announces First Patient Enrolled in U.S. Government- Supported COVID-19 Study - Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K ...

RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering - Vimarsana News

RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering

/PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has closed...

RedHill Biopharma Announces $8 Million Registered Direct Offering - Vimarsana News

RedHill Biopharma Announces $8 Million Registered Direct Offering

/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered...

RedHill Biopharma : and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola - Form 6-K -December 20, 2023 at 08:58 am EST - Vimarsana News

RedHill Biopharma : and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola - Form 6-K -December 20, 2023 at 08:58 am EST

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K ...

RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement - Vimarsana News

RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it received...